athenahealth, Inc. (NASDAQ:ATHN) had its target price hoisted by equities research analysts at Oppenheimer Holdings, Inc. from $154.00 to $184.00 in a research note issued to investors on Friday. The brokerage currently has an “outperform” rating on the health services provider’s stock. Oppenheimer Holdings, Inc.’s price target points to a potential upside of 27.96% from the stock’s previous close.

A number of other research firms have also recently issued reports on ATHN. Barclays PLC set a $88.00 price objective on shares of athenahealth and gave the stock an “underweight” rating in a research report on Monday, May 1st. Jefferies Group LLC reiterated a “hold” rating and set a $135.00 price objective on shares of athenahealth in a research report on Monday, June 26th. Stifel Nicolaus reiterated a “hold” rating and set a $151.00 price objective (up from $106.00) on shares of athenahealth in a research report on Friday, June 16th. Evercore ISI reiterated an “outperform” rating and set a $147.00 price objective (up from $118.00) on shares of athenahealth in a research report on Friday, May 19th. Finally, Leerink Swann set a $140.00 price objective on shares of athenahealth and gave the stock a “hold” rating in a research report on Friday, May 19th. One investment analyst has rated the stock with a sell rating, fourteen have issued a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $143.33.

Shares of athenahealth (NASDAQ:ATHN) traded up 7.39% during mid-day trading on Friday, reaching $154.42. 1,682,968 shares of the company’s stock traded hands. athenahealth has a 12 month low of $90.11 and a 12 month high of $158.66. The stock has a market cap of $6.15 billion, a PE ratio of 303.98 and a beta of 1.79. The firm has a 50 day moving average price of $141.51 and a 200-day moving average price of $122.62.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, beating the consensus estimate of $0.39 by $0.12. The company had revenue of $301.10 million during the quarter, compared to analysts’ expectations of $298.68 million. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.34 EPS. On average, analysts predict that athenahealth will post $1.86 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was first published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/07/21/oppenheimer-holdings-inc-increases-athenahealth-inc-nasdaqathn-price-target-to-184-00.html.

In other news, SVP Jonathan D. Porter sold 300 shares of the company’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $143.13, for a total value of $42,939.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Bradford Kyle Armbrester sold 2,431 shares of the company’s stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $130.00, for a total transaction of $316,030.00. The disclosure for this sale can be found here. Insiders have sold a total of 25,683 shares of company stock worth $3,329,871 over the last three months. Insiders own 3.20% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. bought a new position in shares of athenahealth during the fourth quarter valued at about $118,000. Comerica Bank bought a new position in shares of athenahealth during the fourth quarter valued at about $299,000. GSA Capital Partners LLP bought a new position in shares of athenahealth during the fourth quarter valued at about $307,000. Norges Bank bought a new position in shares of athenahealth during the fourth quarter valued at about $20,750,000. Finally, Quadrature Capital Ltd bought a new position in shares of athenahealth during the fourth quarter valued at about $5,759,000.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.